GRB2 and non-small cell lung carcinoma: More importantly, Jiang et al. reported that miR-1258 was downregulated in NSCLC and inhibited cell proliferation, migration and angiogenesis by targeting GRB2 [18], indicating the inhibitive influences of miR-1258 on the growth and metastasis of NSCLC.